Study Data


NMR Study

Project uploaded by: Neel Sarovar
Project ID: IMP_100036
Title: NMR based human gut metabolomic profiling reveals altered metabolites associated with pulmonary and extra-pulmonary tuberculosis
Project Description: Introduction: Tuberculosis remains one of the world's deadliest infectious diseases. The pathophysiology of the two manifestations of Mycobacterium tuberculosis infection, pulmonary TB (PTB) and extrapulmonary TB (EPTB) is still not fully understood. Understanding the metabolic profile of both disease manifestations in patients is important for developing therapeutic approaches and molecular diagnosis. Objective: The current study aimed to elucidate differences in the gut metabolic profile of PTB and EPTB patients compared to healthy controls (HCs). Method: We used an untargeted approach through 1 H Nuclear Magnetic Resonance (NMR) spectroscopy to perform metabolomic profiling of stool samples from 77 TB patients [pulmonary TB (PTB, n = 33), cervical lymph node TB (CrLNTB, n =30), abdominal TB (ATB, n = 14)], and 30 HCs. Multivariate and univariate analyses were performed to identify the differential gut metabolites associated with TB patients. Results: The PTB patients had higher metabolic perturbation than EPTB patients compared to HCs. The top three significantly altered metabolites, namely valine, N-formyl-L- methionine and dimethylsulfone, were used to generate random forest model to distinguish between TB patients and HCs. The receiver operating characteristics curve analysis was used to assess the performance of the model with area under curve score of 0.831, capable to distinguish TB patients from HCs. Thus, our findings offer insights into the gut metabolome of TB patients in India and characterizes for the first time metabolic perturbations in EPTB patients. Conclusion: The study highlights the metabolic disruptions associated with PTB and EPTB patients.
Research Area: Biological Sciences
Funding Source: JC bose fellowship, ICGEB core fund, Insitute of eminence, DU.
Project Contributors: Vishal Sharma , Anoop Singh , Sonam Sharma , Mohita Gaur , Arun Kumar Malaisamy , Deepti Rawat , Anjali Yadav , Bolaji Fatai Oyeyemi , Aarushi Vasudeva , Anil Chaudhry , Ashwani Khanna , Vishal Khanna , Sheelu Lohiya , Reema Arora , Anannya Bandyopadhyay , Neel Sarovar Bhavesh, Yogendra Singh, Richa Misra

Study uploaded by: Neel Sarovar
Study ID: IMS_100030
Title: NMR based human gut metabolomic profiling reveals altered metabolites associated with pulmonary and extra-pulmonary tuberculosis
Summary: Introduction: Tuberculosis remains one of the world's deadliest infectious diseases. The pathophysiology of the two manifestations of Mycobacterium tuberculosis infection, pulmonary TB (PTB) and extrapulmonary TB (EPTB) is still not fully understood. Understanding the metabolic profile of both disease manifestations in patients is important for developing therapeutic approaches and molecular diagnosis. Objective: The current study aimed to elucidate differences in the gut metabolic profile of PTB and EPTB patients compared to healthy controls (HCs). Method: We used an untargeted approach through 1 H Nuclear Magnetic Resonance (NMR) spectroscopy to perform metabolomic profiling of stool samples from 77 TB patients [pulmonary TB (PTB, n = 33), cervical lymph node TB (CrLNTB, n =30), abdominal TB (ATB, n = 14)], and 30 HCs. Multivariate and univariate analyses were performed to identify the differential gut metabolites associated with TB patients. Results: The PTB patients had higher metabolic perturbation than EPTB patients compared to HCs. The top three significantly altered metabolites, namely valine, N-formyl-L- methionine and dimethylsulfone, were used to generate random forest model to distinguish between TB patients and HCs. The receiver operating characteristics curve analysis was used to assess the performance of the model with area under curve score of 0.831, capable to distinguish TB patients from HCs. Thus, our findings offer insights into the gut metabolome of TB patients in India and characterizes for the first time metabolic perturbations in EPTB patients. Conclusion: The study highlights the metabolic disruptions associated with PTB and EPTB patients.
Keywords: Tuberculosis, diagnosis, pulmonary TB, extra-pulmonary TB, 1H NMR spectroscopy, gut metabolites
Publication: Metabolomics
Release Date: July 22, 2025
Study Type: Nuclear Magnetic Resonance (NMR)
Data Type: Untargeted
IEC/IBSC Approval Number : 2653/RBIPMT/2019

Sr.No Sample ID Sample Name Organism Source Sample Preparation Protocol Sample Type Experimental Condition Time of treatment Variant/Variety Gender Age Replicates Storage Conditions Extraction Protocol Number of files per sample
1 IMSM_101559 Exp 31 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA F 30 NA -80

NA

2 IMSM_101560 Exp 33 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA M 30 NA -80

NA

3 IMSM_101561 Exp 35 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA F 28 NA -80

NA

4 IMSM_101562 Exp 54 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA F 18 NA -80

NA

5 IMSM_101563 Exp 55 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA M 22 NA -80

NA

6 IMSM_101564 Exp 38 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA M 23 NA -80

NA

7 IMSM_101565 Exp 57 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA M 18 NA -80

NA

8 IMSM_101566 Exp 56 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA M 40 NA -80

NA

9 IMSM_101567 Exp 71 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA F 23 NA -80

NA

10 IMSM_101568 Exp 81 Homo sapiens | 9606 Stool The frozen stool aliquots were thawed and ~200 mg of the sample was weighed into a sterile microcentrifuge tube. The samples were homogenized in 600μl of autoclaved Milli-Q water for 2-3 minutes before centrifugation at 15,000g for 15 minutes. 400μl of supernatant was transferred to a fresh microcentrifuge tube, and 200μl of 0.1M potassium phosphate buffer pH 7.4 in D 2 O (0.2 M of K 2 HPO 4 and KH 2 PO 4 , containing 10% (w/v) 4,4-dimethyl-4-silapentane-1- sulfonic acid (DSS), a reference compound), was added to each sample. The sample was vortexed, centrifuged, and loaded into the 5 mm NMR tube for 1 H NMR spectra acquisition. CrLN TB TB NA NA F 15 NA -80

NA

Sr.No NMR Exp ID Sample Name/ID Reference Standard NMR Instrument Name NMR Instrument Type NMR Experiment Type NMR Spectrometer Frequency NMR Probe NMR Probe temperature NMR Solvent NMR tube size Data Transformation (Software/s Used)
1 IME_100804 Exp 31 / IMSM_101559 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
2 IME_100805 Exp 33 / IMSM_101560 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
3 IME_100806 Exp 35 / IMSM_101561 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
4 IME_100807 Exp 54 / IMSM_101562 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
5 IME_100808 Exp 55 / IMSM_101563 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
6 IME_100809 Exp 38 / IMSM_101564 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
7 IME_100810 Exp 57 / IMSM_101565 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
8 IME_100811 Exp 56 / IMSM_101566 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
9 IME_100812 Exp 71 / IMSM_101567 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA
10 IME_100813 Exp 81 / IMSM_101568 DSS Bruker Avance III 500MHz Solution NMR 1D 1H 500 5 mm triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient 298k D2O 5 mm NA

Sr.No First name Last name Email Organization Designation
1 Richa Misra richamisra@svc.ac.in University of Delhi principal_investigator
2 Yogendra Singh ysinghdu@gmail.com University of Delhi co_principal_investigator
3 Neel Sarovar Bhavesh neelsb@icgeb.res.in ICGEB co_principal_investigator
4 Anannya Bandyopadhyay anannya@zoology.du.ac.in University of Delhi research_scholar
5 Reema Arora arorareema1569@gmail.com Lok Nayak Hospital research_scholar
6 Sheelu Lohiya drsheelulohiya@gmail.com Lok Nayak Hospital research_scholar
7 Vishal Khanna dr.vishalkhanna@reddif.com Lok Nayak Hospital research_scholar
8 Ashwani Khanna dr.vishalkhanna@reddif.com Lok Nayak Hospital research_scholar
9 Anil Chaudhry dranilchaudhry@gmail.com Rajan Babu Institute of Pulmonary Medicine and Tuberculosis research_scholar
10 Aarushi Vasudeva aarushi_vasudeva@yahoo.com University of Delhi research_scholar
11 Bolaji Fatai Oyeyemi bolajioyeyemi@gmail.com ICGEB research_scholar
12 Anjali Yadav anniey2411@gmail.com University of Delhi research_scholar
13 Deepti Rawat deeptirawat0397@gmail.com University of Delhi research_scholar
14 Arun Kumar Malaisamy makias191@gmail.com ICGEB research_scholar
15 Mohita Gaur m.mohitagaur@gmail.com University of Delhi research_scholar
16 Sonam Sharma sonamsharmamr@gmail.com ICGEB research_scholar
17 Anoop Singh anoop.singh.du@gmail.com University of Delhi research_scholar
18 Vishal Sharma s.vishalzoology@gmail.com University of Delhi research_scholar

Sr.No ftprun ID NMR Exp ID NMR Data Files
101 IMR_101503 IME_100904 239.zip
102 IMR_101504 IME_100905 240.zip
103 IMR_101505 IME_100906 241.zip
104 IMR_101506 IME_100907 242.zip
105 IMR_101507 IME_100908 243.zip
106 IMR_101508 IME_100909 244.zip
107 IMR_101509 IME_100910 245.zip